Metastatic Brain Tumors: Current Therapeutic Options and Historical Perspective
Document Type
Article
Publication Date
5-1-2013
Abstract
Metastatic brain tumors affect more than 150,000 patients annually in the United States. The therapeutic paradigms for these tumors have evolved over the years and currently encompass numerous modalities implemented by treating physicians across several medical disciplines. The armamentarium of brain tumor treatment involves neurosurgical intervention, whole-brain and focused radiation modalities, chemotherapy, and immunotherapy. Patient selection, however, remains critical to achieve maximal therapeutic benefit and depends on functional status, number and location of lesions, and tissue histologic findings. Best outcomes can be expected with a multidisciplinary approach to patient care where state-of-the-art treatment options are readily available.
Publication Title
Journal of the American Osteopathic Association
Volume
113
Issue
5
First Page
418
Last Page
423
PubMed ID
23667195
Recommended Citation
Rivkin, Mark and Kanoff, Richard B., "Metastatic Brain Tumors: Current Therapeutic Options and Historical Perspective" (2013). PCOM Scholarly Works. 128.
https://digitalcommons.pcom.edu/scholarly_papers/128
Comments
This article was published in Journal of the American Osteopathic Association, Volume 113, Issue 5, May 2013, Pages 418-23.
The published version is available at http://www.jaoa.org/content/113/5/418.long
Copyright © 2013 by the American Osteopathic Association